Early Wednesday, Boston Scientific (BSX) reported adjusted profit of 45 cents per share on $3.13 billion in sales for the fourth quarter. In response, BSX stock skidded.
On average, analysts polled by FactSet expected Boston Scientific to earn 44 cents per share on $3.11 billion in sales.
In the year-earlier period, the medical products company earned 23 cents per share and reported $2.71 billion in sales.
For the year ending in December 2022, Boston Scientific guided to 6%-8% sales growth, on both a strict as-reported and organic basis. That would fall from 20% growth in 2021. The company also expect to earn $1.73-$1.79 a share. BSX stock analysts projected adjusted profit of $1.87 per share and $12.93 billion in sales, up 9%.
https://www.investors.com/news/technology/bsx-stock-boston-scientific-earnings-q4-2021/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.